July 16, 2025Open Access

Cell-free DNA fragmentomic characteristics in transposon elements inform molecular regulators and enhance cancer diagnosis

View Full Paper

Ask AI

Bookmark

Fragmentomics of cell-free DNA in transposon elements reveal significant features linked to cancer.
Dynamics of fragmentomic characteristics correlate with epigenomic features like DNA methylation.
AI models using cfDNA fragmentomic data demonstrate improved cancer diagnostic performance in over 1600 samples.
Changes in cfDNA coverage within transposon elements provide insights into regulatory mechanisms in cancer biology.

Discussion

No takes yet. Share an insight, caveat, or question.

Investigation reveals fragmentomics dynamics in transposon elements enhance cancer diagnosis, suggesting new biomarker potential.

Gong et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark